Financial Performance - Operating revenue for Q1 2025 reached CNY 47,253,258.03, a growth of 10.36% year-on-year[9] - Net profit attributable to shareholders decreased by 71.60% to CNY 3,823,967.56 compared to the same period last year[9] - Total operating revenue for Q1 2025 reached ¥47,253,258.03, an increase from ¥42,818,736.92 in Q1 2024, representing a growth of approximately 10.1%[32] - Total operating costs for Q1 2025 were ¥42,920,972.75, up from ¥33,582,034.05 in Q1 2024, indicating a rise of about 27.8%[32] - Net profit for Q1 2025 was ¥3,823,967.56, a decrease from ¥13,466,468.02 in Q1 2024, reflecting a decline of approximately 71.6%[33] - The operating profit for Q1 2025 was ¥4,479,568.72, down from ¥9,149,827.67 in Q1 2024, showing a decrease of about 51.0%[33] - Total comprehensive income for Q1 2025 was ¥3,823,967.56, down from ¥13,466,468.02 in Q1 2024, reflecting a decline of approximately 71.6%[33] - The company’s total profit for Q1 2025 was ¥4,479,136.84, down from ¥15,747,177.43 in Q1 2024, indicating a decrease of about 71.5%[33] Cash Flow - Cash flow from operating activities turned negative at CNY -3,911,730.98, a decline of 141.06% year-on-year[9] - The net cash flow from operating activities for Q1 2025 was -3,911,730.98 CNY, compared to 9,526,305.88 CNY in Q1 2024, indicating a significant decline[38] - Total cash inflow from operating activities in Q1 2025 was 56,536,130.04 CNY, while cash outflow was 47,009,824.16 CNY, resulting in a net cash flow of 9,526,305.88 CNY for Q1 2024[38] - Cash inflow from investment activities in Q1 2025 was 19,054,553.01 CNY, while cash outflow was 38,656,920.67 CNY, leading to a net cash flow of -19,602,367.66 CNY[38] - Cash inflow from financing activities in Q1 2025 was 57,132,021.50 CNY, with cash outflow of 25,768,064.40 CNY, resulting in a net cash flow of 31,363,957.10 CNY[38] - The ending cash and cash equivalents balance for Q1 2025 was 60,192,344.95 CNY, compared to 81,401,204.59 CNY at the end of Q1 2024[38] - The company reported a total cash inflow from operating activities of 58,299,296.59 CNY in Q1 2025, slightly up from 56,505,697.27 CNY in Q1 2024[39] - The cash outflow for operating activities in Q1 2025 was 67,107,413.25 CNY, compared to 46,584,321.54 CNY in Q1 2024, reflecting increased operational costs[40] - The net increase in cash and cash equivalents for Q1 2025 was 7,835,501.20 CNY, compared to 20,018,654.43 CNY in Q1 2024[38] Assets and Liabilities - Total assets increased by 6.37% to CNY 605,759,736.15 compared to the end of the previous year[9] - The company's debt-to-asset ratio rose to 38.70% from 35.57% year-on-year[9] - The total current assets as of March 31, 2025, amounted to CNY 216,793,521.34, an increase from CNY 187,437,160.25 as of December 31, 2024, reflecting a growth of approximately 15.6%[26] - Cash and cash equivalents increased to CNY 61,192,344.95 from CNY 53,351,523.62, representing a growth of about 14.5%[26] - Inventory increased by 33.70% to CNY 76,863,269.86, indicating a rise in raw material reserves[10] - The total liabilities decreased from CNY 56,861,000 to CNY 54,030,700, a reduction of about 5.0%[19] - Total liabilities rose to ¥234,436,789.59, compared to ¥202,587,122.95, indicating an increase of about 15.71%[28] - Non-current liabilities increased significantly to ¥81,580,477.35 from ¥50,337,596.23, marking a growth of approximately 62.06%[27] - Current liabilities totaled ¥152,856,312.24, slightly up from ¥152,249,526.72, reflecting a marginal increase of 0.40%[27] - Shareholders' equity reached ¥371,322,946.56, an increase from ¥366,880,874.29, showing a growth of about 1.21%[28] Research and Development - Research and development expenses increased by 76.73% to CNY 2,884,568.59, reflecting higher investment in new technologies[11] - Research and development expenses increased to ¥2,884,568.59 in Q1 2025 from ¥1,632,169.19 in Q1 2024, marking a rise of approximately 76.7%[32] Shareholder Information - The number of ordinary shareholders increased to 4,207, with total shares outstanding remaining at 76,981,929[16] - The number of major shareholders holding more than 5% of shares remains stable, with the largest shareholder, Li Li, holding 40.84%[19] Compliance and Legal Matters - The company has maintained compliance with internal review procedures for major events and disclosures[21] - There were no significant legal disputes or arbitration matters reported during the period[21] - The company has not engaged in any external borrowing activities during the reporting period[21] - The company has not announced any new product developments or market expansions in this reporting period[22]
中草香料(920016) - 2025 Q1 - 季度财报